{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T14:16:29Z","timestamp":1790691389308,"version":"4.1.0"},"reference-count":17,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Cedars-Sinai Medical Center institutional funding"},{"name":"Diana and Steve Marienhoff Fashion Industries Guild Endowed Fellowship"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","nmd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuromuscular Disorders"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1016\/j.nmd.2015.09.007","type":"journal-article","created":{"date-parts":[[2015,9,16]],"date-time":"2015-09-16T13:26:12Z","timestamp":1442409972000},"page":"959-963","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"title":["Acid ceramidase deficiency associated with spinal muscular atrophy with progressive myoclonic epilepsy"],"prefix":"10.1016","volume":"25","author":[{"given":"Joanna J.","family":"Gan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginie","family":"Garcia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Tagliati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph E.","family":"Parisi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey M.","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Lewis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Baloh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thierry","family":"Levade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tyler Mark","family":"Pierson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nmd.2015.09.007_bib0010","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.ajhg.2012.05.001","article-title":"Spinal muscular atrophy associated with progressive myoclonic epilepsy is caused by mutations in ASAH1","volume":"91","author":"Zhou","year":"2012","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.nmd.2015.09.007_bib0015","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1016\/j.bbamem.2006.08.019","article-title":"Acid ceramidase and human disease","volume":"1758","author":"Park","year":"2006","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.nmd.2015.09.007_bib0020","doi-asserted-by":"crossref","first-page":"29948","DOI":"10.1074\/jbc.M303310200","article-title":"The reverse activity of human acid ceramidase","volume":"278","author":"Okino","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.nmd.2015.09.007_bib0025","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.ymgme.2013.04.019","article-title":"Molecular basis of acid ceramidase deficiency in a neonatal form of Farber disease: identification of the first large deletion in ASAH1 gene","volume":"109","author":"Alves","year":"2013","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.nmd.2015.09.007_bib0030","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1111\/cge.12307","article-title":"Evidence for clinical, genetic and biochemical variability in spinal muscular atrophy with progressive myoclonic epilepsy","volume":"86","author":"Dyment","year":"2014","journal-title":"Clin Genet"},{"key":"10.1016\/j.nmd.2015.09.007_bib0035","doi-asserted-by":"crossref","DOI":"10.1111\/epi.12977","article-title":"Spinal muscular atrophy associated with progressive myoclonic epilepsy: a rare condition caused by mutations in ASAH1","author":"Rubboli","year":"2015","journal-title":"Epilepsia"},{"key":"10.1016\/j.nmd.2015.09.007_bib0040","doi-asserted-by":"crossref","first-page":"3542","DOI":"10.1194\/jlr.D010033","article-title":"A simple fluorogenic method for determination of acid ceramidase activity and diagnosis of Farber disease","volume":"51","author":"Bedia","year":"2010","journal-title":"J Lipid Res"},{"key":"10.1016\/j.nmd.2015.09.007_bib0045","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1002\/emmm.201202301","article-title":"Systemic ceramide accumulation leads to severe and varied pathological consequences","volume":"5","author":"Alayoubi","year":"2013","journal-title":"EMBO Mol Med."},{"key":"10.1016\/j.nmd.2015.09.007_bib0050","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.nmd.2014.11.007","article-title":"Uniparental disomy as a cause of spinal muscular atrophy and progressive myoclonic epilepsy: phenotypic homogeneity due to the homozygous c.125C>T mutation in ASAH1","volume":"25","author":"Gir\u00e1ldez","year":"2014","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.nmd.2015.09.007_bib0055","first-page":"116","article-title":"Hereditary myoclonus and progressive muscular atrophy: a new syndrome","volume":"103","author":"Jankovic","year":"1978","journal-title":"Trans Am Neurol Assoc"},{"key":"10.1016\/j.nmd.2015.09.007_bib0060","first-page":"141","article-title":"Progressive myoclonic epilepsy, nerve deafness and spinal muscular atrophy","volume":"20","author":"Lance","year":"1984","journal-title":"Clin Exp Neurol"},{"key":"10.1016\/j.nmd.2015.09.007_bib0065","first-page":"313","article-title":"Unusual familial association of epilepsy, myoclonus and muscular atrophy. Case report","volume":"55","author":"D'Ecclesia","year":"1985","journal-title":"Riv Neurol"},{"key":"10.1016\/j.nmd.2015.09.007_bib0070","first-page":"201","article-title":"Progressive familial myoclonic epilepsy with bulbo-spinal amyotrophy. Clinical, electrophysiological study, and biopsy of a case","volume":"60","author":"Taglioli","year":"1990","journal-title":"Riv Neurol"},{"key":"10.1016\/j.nmd.2015.09.007_bib0075","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/0887-8994(93)90053-F","article-title":"Association of progressive myoclonic epilepsy and spinal muscular atrophy","volume":"9","author":"Marjanovic","year":"1993","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.nmd.2015.09.007_bib0080","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1055\/s-2002-37087","article-title":"Spinal muscular atrophy with progressive myoclonic epilepsy: report of new cases and review of the literature","volume":"33","author":"Haliloglu","year":"2002","journal-title":"Neuropediatrics"},{"key":"10.1016\/j.nmd.2015.09.007_bib0085","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.seizure.2004.01.008","article-title":"Spinal muscular atrophy and progressive myoclonic epilepsy: one case report and characteristics of the epileptic syndrome","volume":"13","author":"Striano","year":"2004","journal-title":"Seizure"},{"issue":"10","key":"10.1016\/j.nmd.2015.09.007_bib0090","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1111\/j.1528-1167.2008.01651.x","article-title":"A rare phenotype: progressive myoclonic epilepsy with lower motor neuron involvement","volume":"49","author":"Temucin","year":"2008","journal-title":"Epilepsia"}],"container-title":["Neuromuscular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960896615007348?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960896615007348?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T08:04:16Z","timestamp":1760774656000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960896615007348"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12]]},"references-count":17,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["S0960896615007348"],"URL":"https:\/\/doi.org\/10.1016\/j.nmd.2015.09.007","relation":{},"ISSN":["0960-8966"],"issn-type":[{"value":"0960-8966","type":"print"}],"subject":[],"published":{"date-parts":[[2015,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Acid ceramidase deficiency associated with spinal muscular atrophy with progressive myoclonic epilepsy","name":"articletitle","label":"Article Title"},{"value":"Neuromuscular Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nmd.2015.09.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}